×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALXO – alx oncology holdings inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALXO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
09:10 am
alxo
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors [Yahoo! Finance]
Medium
Report
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors [Yahoo! Finance]
11/14
08:12 am
alxo
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer [Yahoo! Finance]
Low
Report
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer [Yahoo! Finance]
11/14
08:00 am
alxo
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer
Low
Report
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer
11/12
09:03 am
alxo
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
High
Report
ALX Oncology Holdings Inc. (NASDAQ: ALXO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
11/7
04:00 pm
alxo
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/4
08:00 am
alxo
ALX Oncology Announces November Investor Conference Participation
Neutral
Report
ALX Oncology Announces November Investor Conference Participation
11/1
05:33 pm
alxo
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 [Yahoo! Finance]
Low
Report
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 [Yahoo! Finance]
11/1
05:30 pm
alxo
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
Neutral
Report
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
04:00 pm
alxo
alx oncology holdings inc.
BEAT
Report
-4.6%
alx oncology holdings inc.
8/8/2024
04:05 pm
alxo
alx oncology holdings inc.
BEAT
Report
-0.8%
alx oncology holdings inc.
5/9/2024
04:00 pm
alxo
alx oncology holdings inc.
BEAT
Report
-4.4%
alx oncology holdings inc.
Date
Time
Symbol
Headline
Impact
11/19
04:06 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Nov 18 Filed by: Sandler Alan B.
Low
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Nov 18 Filed by: Sandler Alan B.
11/14
07:23 pm
alxo
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: ORBIMED ADVISORS LLC
Medium
Report
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: ORBIMED ADVISORS LLC
11/14
06:58 pm
alxo
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: Vivo Capital Fund IX, L.P.
Medium
Report
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: Vivo Capital Fund IX, L.P.
11/14
03:03 pm
alxo
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: Cormorant Asset Management, LP
Low
Report
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: Cormorant Asset Management, LP
11/14
08:03 am
alxo
Form 8-K ALX ONCOLOGY HOLDINGS For: Nov 08
Low
Report
Form 8-K ALX ONCOLOGY HOLDINGS For: Nov 08
11/12
09:51 am
alxo
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: FMR LLC
Medium
Report
Form SC 13G/A ALX ONCOLOGY HOLDINGS Filed by: FMR LLC
11/7
04:07 pm
alxo
Form 10-Q ALX ONCOLOGY HOLDINGS For: Sep 30
Medium
Report
Form 10-Q ALX ONCOLOGY HOLDINGS For: Sep 30
11/7
04:03 pm
alxo
Form 8-K ALX ONCOLOGY HOLDINGS For: Nov 05
Medium
Report
Form 8-K ALX ONCOLOGY HOLDINGS For: Nov 05
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: